Consistent with our in vitro data, expression of KLK6, p53, ATG5 and LC3B activation in tumor lysates from AF-treated mice with tumors from KLK6-overexpressing cells was higher than that in lysates from mock-transfected cell tumors (Figure 5C). The gene discussed is MAP1LC3B; the disease is neoplasm.